🔴 Pyxis Oncology is trading 5% down today amid biotech weakness, with no clear company-specific catalyst

Pyxis Oncology is trading at $1.91 (-5.22%) amid biotech-sector weakness; available evidence does not establish a direct cause.

• No clear Pyxis Oncology-specific announcement for October 13 surfaced among the company’s listed releases; its latest listed release was the October 2 public-offering closing.
• The supplied sector context shows XBI down 2.01%.
• Recent industry coverage describes cautious biotech sentiment amid trial setbacks and rising rates.